Medical or interventional therapy for rhythm control in atrial fibrillation (antiarrhythmic drugs, ablation, electric cardio version) for atrial fibrillation
A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set
Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.
Put together by software, not yet checked by a person
Why this status
24 Mar 2022: Trial registered, NCT05293080
6 Nov 2025: Trial started, NCT05293080
The trials
NCT05293080: Early Treatment of Atrial Fibrillation for Stroke Prevention Trial in Acute STROKE
State
Under way
Phase
Phase 3
People
1,746 planned
Started
6 Nov 2025
Primary completion
Jul 2031
Arms
Early rhythm control therapy
Results
None posted
24 Mar 2022: Trial registered
6 Nov 2025: Trial started
How the status changed
19 Nov 2026: First set: Phase 3 trial
Registries searched: ClinicalTrials.gov, through 17 Nov 2026.